The Biotech Market Is on Fire

By: ...

MoneyMorning.com Spending on drugs here in the United States increased 13% last year to $374 billion – the single-biggest one-year jump in history. That’s a record-setting 4.3 billion prescriptions filled.

That means spending on drugs is rising at a rate that’s five times faster than the growth of the overall economy.

In other words, despite all the “noise” about biotech being “overheated,” the sector remains full of terrific investment opportunities.

Today, I’m talking with Money Map Press Executive Editor William Patalon III about biotech investing – including specific investments you should be making.

And you can listen in…

The Moves You Need to Make

Mergers and acquisitions, the aging U.S. population and the Food and Drug Administration’s new “Breakthrough Therapy” status are just some of the reasons biotech and pharmaceuticals continue to make millionaires out of everyday investors.

However, there’s another area, which most investors never even consider, that’s going to be big… really big.

In this conversation with Bill Patalon, we talk about how that’s where The Biotech Deal of the Century is coming together right now.

Source :http://strategictechinvestor.com/2015/07/the-biotech-market-is-on-fire/

Money Morning/The Money Map Report

©2015 Monument Street Publishing. All Rights Reserved. Protected by copyright laws of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), of content from this website, in whole or in part, is strictly prohibited without the express written permission of Monument Street Publishing. 105 West Monument Street, Baltimore MD 21201, Email: customerservice@moneymorning.com

Disclaimer: Nothing published by Money Morning should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investent advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication, or after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended by Money Morning should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.

© 2005-2022 http://www.MarketOracle.co.uk - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.